Explore our resources by research/diagnostic specialty or content type

ALPCO specialists are leveraging their extensive expertise to create a growing collection of resources for your research and testing. Find resources that benefit your work using the handy filters.

Incretins GIP and GLP-1 in Diabetes and Obesity
April 20, 2023

Incretins GIP and GLP-1 in Diabetes and Obesity

800 million people worldwide struggle with obesity, a disease that will cost over $1 trillion in medical consequences by 2025.  The CDC reports severe obesity leads to life-altering and often life-threatening conditions like heart disease, stroke, type 2 diabetes, and certain cancers.

What is the “Incretin Effect”?

To help understand the mechanisms behind obesity and to develop treatments, researchers study several hormones, including incretin hormones GIP and GLP-1.  Learn more about the incretins, their well-published “incretin effect,” and their potential relationship to obesity by downloading our free article “The Role of Incretins GIP and GLP-1 in Diabetes and Obesity" on the right.

Incretins GIP and GLP-1 Article

Related posts